✦ LIBER ✦

Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell lung cancer

✍ Scribed by David S. Binns; Andrea Pirzkall; Wei Yu; Jason Callahan; Linda Mileshkin; Peter Conti; Andrew M. Scott; David Macfarlane; Bernard M. Fine; Rodney J. Hicks; OSI3926g Study Team

Publisher: Springer
Year: 2011
Tongue: English
Weight: 211 KB
Volume: 38
Category: Article
ISSN: 0340-6997
DOI: 10.1007/s00259-010-1665-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

N-telopeptide of type I collagen is usef

N-telopeptide of type I collagen is useful for monitoring therapeutic response in non-small cell lung cancer patients with bone metastases

✍ Rieko Kaira; Haruyasu Murakami; Kyoichi Kaira; Toshiaki Takahashi; Asuka Tsuya; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 162 KB

Is FDG-PET suitable for evaluating neoad

Is FDG-PET suitable for evaluating neoadjuvant therapy in non-small cell lung cancer? Evidence with systematic review of the literature

✍ Ángel C. Rebollo-Aguirre; Carlos Ramos-Font; Román Villegas Portero; Gary J.R. C 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 1 views

Target volume definition for18F-FDG PET-

Target volume definition for18F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer

✍ Ursula Nestle; Andrea Schaefer-Schuler; Stephanie Kremp; Andreas Groeschel; Dirk 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 301 KB

Diagnostic Performance of18F-FDG PET/CT

Diagnostic Performance of18F-FDG PET/CT for Lymph Node Staging in Patients with Operable Non-small-cell Lung Cancer and Inflammatory Lung Disease

✍ Young-Sil An; Joo Sung Sun; Kyung Joo Park; Sung Chul Hwang; Kwang Joo Park; Seu 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 273 KB

Effect of Histologic Type on Recurrence

Effect of Histologic Type on Recurrence Pattern in Radiation Therapy for Medically Inoperable Patients with Stage I Non-Small-Cell Lung Cancer

✍ Hitoshi Ishikawa; Yuko Nakayama; Yoshizumi Kitamoto; Tetsuo Nonaka; Hidemasa Kaw 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 86 KB

Serum levels of CA19-9 may be as an indi

Serum levels of CA19-9 may be as an indicator for metastases in patients with non-small cell lung cancer

✍ Xing’an Liu; Guoyong Shan; Song Zhang; Kaijian Lei 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 314 KB